The global intrauterine contraceptive devices market size was valued at USD 5.58 billion in 2025 and is projected to grow from USD 5.79 billion in 2026 to USD 7.82 billion by 2034 at a CAGR of 3.82% during the forecast period 2026–2034. Europe dominated the intrauterine contraceptive devices market with a share of 34.2% in 2025.
Download a Free Sample To learn more about this report,
The Intrauterine Contraceptive Devices (IUCD) Market refers to the global industry involved in the development, manufacturing, distribution, and sale of intrauterine devices used for long-term, reversible contraception. These devices, including hormonal and copper-based IUCDs, are inserted into the uterus to prevent pregnancy. Market growth is driven by increasing awareness of family planning, rising demand for effective contraceptive solutions, and advancements in reproductive healthcare technologies.
Increasing Availability of Next-Generation Copper Intrauterine Devices
The global intrauterine contraceptive devices (IUCD) market is witnessing a shift towards next-generation copper intrauterine devices that are designed to improve patient comfort while maintaining high contraceptive effectiveness. Manufacturers are focusing on smaller, more flexible devices that simplify insertion and reduce discomfort, helping increase acceptance among first-time users and younger women. This trend is expected to expand contraceptive choices and encourage greater adoption of long-acting reversible contraception.
Rising Adoption of Long-Acting Reversible Contraception
The growing preference for long-acting reversible contraception (LARC) is another major trend supporting the intrauterine contraceptive devices market. Healthcare providers increasingly recommend IUCDs because they are over 99% effective, require no daily maintenance, and provide long-term pregnancy prevention while allowing fertility to return quickly after removal. Governments and healthcare organisations are also expanding awareness programmes to improve access to modern contraceptive methods.
Increase in Awareness of These Devices' Availability through Campaigns and Digital Advertisements
Intrauterine Devices (IUDs) are small T-shaped devices implanted in women's uteruses to prevent pregnancy. Copper IUDs and other hormonal contraceptives are widely used. The longevity, efficacy, convenience, and low cost of intrauterine contraceptive devices are just a few factors propelling the market. The demand in the market is heavily influenced by government initiatives that highlight the advantages of using IUDs. Spreading the word about these tools exists solely to feed the market demand, which is true even in developing nations. The market for intrauterine contraceptive devices is expanding rapidly due to both rising demand and the stimulating effect of constant innovation.
In February 2025, the U.S. FDA approved Miudella, a hormone-free copper intrauterine system developed by Sebela Women's Health. The approval introduced a next-generation copper IUD featuring a flexible nitinol frame designed to improve comfort and expand contraceptive options, further increasing awareness and adoption of long-acting reversible contraceptives.
High Cost of the Device
One consideration in selecting a method of birth control is the available budget. An examination of the first-year costs for the various approaches reveals that they can be quite high and that there are significant variations between methods based on fees charged by private physicians and supplies purchased from pharmacies. The global market for intrauterine contraceptive devices may be slowed by factors such as heavy bleeding, irregular bleeding, and cramps. These are also the most common causes for removing an intrauterine device. In terms of preventing the spread of STDs, it is entirely ineffective.
In the United States, the retail cost of an IUD, including consultation and insertion, can exceed USD 1,000 for uninsured patients. Despite long-term cost savings, the high upfront expense remains a major barrier to adoption, particularly among low-income women without adequate health insurance coverage.
Increasing Inclination towards Planned Delayed Pregnancy
Market expansion is anticipated to be fueled by rising demand from women who want to delay having children by choice. Increased interest in postponing pregnancy is predicted to result from the United States government's adoption of innovative strategies to expand access to sexual and reproductive health services and products. The fertility-preventing effectiveness of intrauterine devices is approximately 99% and lasts for 3–10 years. Teenage women are increasing in number across the country. With that comes a greater need for access to and use of contraceptives like intrauterine devices to prevent unsafe abortions and unintended pregnancies. It is adding to the already substantial product adoption to avoid unwanted pregnancies. Market opportunities for IUDs are expected to increase in the coming years due to the far-reaching consequences of unintended pregnancies.
According to the World Health Organization (WHO), around 164 million women globally have an unmet need for modern contraception. Expanding access to long-acting contraceptives such as IUDs through national family planning programmes presents a significant opportunity to reduce unintended pregnancies and improve reproductive health outcomes.
Request Customizationto receive a tailored report.
Hormonal Intrauterine Devices Dominated the Market with 61.5% Share in 2025
Hormonal intrauterine devices accounted for the largest share of the global intrauterine contraceptive devices (IUCD) market at 61.5% in 2025, generating USD 3.43 billion in revenue. The segment's dominance is driven by its high contraceptive effectiveness, long-term protection, reduced menstrual bleeding, and growing preference among women seeking convenient and reversible birth control. The segment is also projected to grow at a CAGR of 4.87% during the forecast period.
Mirena Dominated the Market with 33.4% Share in 2025
Mirena held the largest share of the global intrauterine contraceptive devices market at 33.4% in 2025, accounting for USD 1.86 billion in market value. Its widespread adoption is attributed to its proven safety profile, long-lasting contraceptive protection, and additional therapeutic benefits, including the treatment of heavy menstrual bleeding. Meanwhile, Levosert is projected to register the fastest growth, expanding at a CAGR of 5.38% during the forecast period, supported by increasing product availability and rising adoption across international markets.
Hospitals Dominated the Market with 48.7% Share in 2025
Hospitals accounted for the largest share of the global intrauterine contraceptive devices market at 48.7% in 2025, representing USD 2.72 billion in revenue. The segment's leadership is driven by the availability of skilled healthcare professionals, comprehensive reproductive healthcare services, and a high volume of IUCD insertion and follow-up procedures. Meanwhile, Community Healthcare Centers are expected to witness the fastest growth, registering a CAGR of 4.96% during the forecast period due to expanding government family planning programmes and improved access to primary healthcare services.
Speak to an Analystto discuss market opportunities.
The U.S. Intrauterine Contraceptive Devices Market was valued at USD 1.42 billion in 2025. Market growth is driven by high adoption of long-acting reversible contraceptives (LARCs), favorable reimbursement policies, and continuous product innovations.
The Canada Intrauterine Contraceptive Devices Market was valued at USD 0.23 billion in 2025. Increasing awareness of reproductive health, universal healthcare access, and growing preference for long-term contraception support market growth.
The Germany Intrauterine Contraceptive Devices Market was valued at USD 0.37 billion in 2025. Strong healthcare infrastructure, high contraceptive awareness, and supportive government healthcare policies continue to drive demand.
The U.K. Intrauterine Contraceptive Devices Market was valued at USD 0.24 billion in 2025. Growth is supported by NHS-backed family planning services, increasing use of long-acting reversible contraceptives, and improved access to women's healthcare.
The China Intrauterine Contraceptive Devices Market was valued at USD 0.43 billion in 2025. Expanding family planning initiatives, a large reproductive-age population, and improving healthcare infrastructure are driving market growth.
The Japan Intrauterine Contraceptive Devices Market was valued at USD 0.19 billion in 2025. Rising awareness of modern contraceptive methods and growing investment in women's healthcare are contributing to market expansion.
The Brazil Intrauterine Contraceptive Devices Market was valued at USD 0.16 billion in 2025. Government family planning initiatives, improving access to reproductive healthcare, and rising awareness of long-acting contraceptive methods are driving market expansion.
The UAE Intrauterine Contraceptive Devices Market was valued at USD 0.04 billion in 2025. Increasing healthcare investments, expanding women's health services, and growing awareness of modern contraception are supporting steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com